Table of Content
- 1. Preface
- 2. Assumptions and Research Methodology
- 3. Executive Summary: Global Market
- 4. Market Overview
- 5. Market Outlook
- 6. Global Market Analysis and Forecasts, by Drug Class
- 6.1. Prostaglandins
- 6.2. Beta Blockers
- 6.3. Alpha Agonists
- 6.4. Carbonic Anhydrase Inhibitors
- 6.5. Combination Medications
- 6.6. Cholinergics
- 7. Global Market Analysis and Forecasts, by End-user
- 7.1. Hospitals
- 7.2. Ophthalmic Clinics
- 7.3. Ambulatory Surgical Centers
- 8. Global Market Analysis and Forecasts, by Region
- 8.1. North America
- 8.2. Europe
- 8.3. Asia Pacific
- 8.4. Latin America
- 8.5. Middle East & Africa
- 9. North America Market Analysis and Forecast
- 10. Europe Market Analysis and Forecast
- 11. Asia Pacific Market Analysis and Forecast
- 12. Latin America Market Analysis and Forecast
- 13. Middle East & Africa Market Analysis and Forecast
- 14. Competition Landscape
- 14.1. Allergan plc
- 14.2. Merck & Co., Inc.
- 14.3. Novartis AG
- 14.4. Pfizer Inc.
- 14.5. Santen Pharmaceuticals Co. Ltd.
- 14.6. Valeant Pharmaceuticals International, Inc.
- 14.7. Aerie Pharmaceuticals Inc.
List of Tables
Table 01: Global Market Size (US$ Mn) Forecast, by Drug Class, 2021 to 2031
Table 02: Global Market Size (US$ Mn) Forecast, by End-user, 2021 to 2031
Table 03: Global Market Size (US$ Mn) Forecast, by Region, 2021 to 2031
Table 04: North America Market Value (US$ Mn) Forecast, by Drug Class, 2021 to 2031
Table 05: North America Market Forecast, by End-user, 2021 to 2031
Table 06: North America Market Value (US$ Mn) Forecast, by Country, 2021 to 2031
Table 07: U.S. Market Forecast, by Drug Class, 2021 to 2031
Table 08: U.S. Market Forecast, by End-user, 2021 to 2031
Table 09: Canada Market Forecast, by Drug Class, 2021 to 2031
Table 10: Canada Market Forecast, by End-user, 2021 to 2031
Table 11: Europe Market Value (US$ Mn) Forecast, by Drug Class, 2021 to 2031
Table 12: Europe Market Forecast, by End-user, 2021 to 2031
Table 13: Europe Market Value (US$ Mn) Forecast, by Country/Sub-region, 2021 to 2031
Table 14: U.K. Market Forecast, by Drug Class, 2021 to 2031
Table 15: U.K. Market Forecast, by End-user, 2021 to 2031
Table 16: Germany Market Forecast, by Drug Class, 2021 to 2031
Table 17: Germany Market Forecast, by End-user, 2021 to 2031
Table 18: France Market Forecast, by Drug Class, 2021 to 2031
Table 19: France Market Forecast, by End-user, 2021 to 2031
Table 20: Spain Market Forecast, by Drug Class, 2021 to 2031
Table 21: Spain Market Forecast, by End-user, 2021 to 2031
Table 22: Italy Market Forecast, by Drug Class, 2021 to 2031
Table 23: Italy Market Forecast, by End-user, 2021 to 2031
Table 24: Rest of Europe Market Forecast, by Drug Class, 2021 to 2031
Table 25: Rest of Europe Market Forecast, by End-user, 2021 to 2031
Table 26: Asia Pacific Market Value (US$ Mn) Forecast, by Drug Class, 2021 to 2031
Table 27: Asia Pacific Market Forecast, by End-user, 2021 to 2031
Table 28: Asia Pacific Market Value (US$ Mn) Forecast, by Country/Sub-region, 2021 to 2031
Table 29: Japan Market Forecast, by Drug Class, 2021 to 2031
Table 30: Japan Market Forecast, by End-user, 2021 to 2031
Table 31: China Market Forecast, by Drug Class, 2021 to 2031
Table 32: China Market Forecast, by End-user, 2021 to 2031
Table 33: India Market Forecast, by Drug Class, 2021 to 2031
Table 34: India Market Forecast, by End-user, 2021 to 2031
Table 35: Australia & New Zealand Market Forecast, by Drug Class, 2021 to 2031
Table 36: Australia & New Zealand Market Forecast, by End-user, 2021 to 2031
Table 37: Rest of APAC Market Forecast, by Drug Class, 2021 to 2031
Table 38: Rest of APAC Market Forecast, by End-user, 2021 to 2031
Table 39: Latin America Market Value (US$ Mn) Forecast, by Drug Class, 2021 to 2031
Table 40: Latin America Market Forecast, by End-user, 2021 to 2031
Table 41: Latin America Market Value (US$ Mn) Forecast, by Country/Sub-region, 2021 to 2031
Table 42: Brazil Market Forecast, by Drug Class, 2021 to 2031
Table 43: Brazil Market Forecast, by End-user, 2021 to 2031
Table 44: Mexico Market Forecast, by Drug Class, 2021 to 2031
Table 45: Mexico Market Forecast, by End-user, 2021 to 2031
Table 46: Rest of LATAM Market Forecast, by Drug Class, 2021 to 2031
Table 47: Rest of LATAM Market Forecast, by End-user, 2021 to 2031
Table 48: Middle East & Africa Market Value (US$ Mn) Forecast, by Drug Class, 2021 to 2031
Table 49: Middle East & Africa Market Forecast, by End-user, 2021 to 2031
Table 50: Middle East & Africa Market Value (US$ Mn) Forecast, by Country/Sub-region, 2021 to 2031
Table 51: GCC Countries Market Forecast, by Drug Class, 2021 to 2031
Table 52: GCC Countries Market Forecast, by End-user, 2021 to 2031
Table 53: South Africa Market Forecast, by Drug Class, 2021 to 2031
Table 54: South Africa Market Forecast, by End-user, 2021 to 2031
Table 55: Rest of MEA Market Forecast, by Drug Class, 2021 to 2031
Table 56: Rest of MEA Market Forecast, by End-user, 2021 to 2031
List of Figures
Figure 01: Global Market Snapshot
Figure 02: Global Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2021 to 2031
Figure 03: Market Value Share, by Drug Class (2020)
Figure 04: Market Value Share, by End-user (2020)
Figure 05: Market Value Share, by Region (2020)
Figure 06: Global Market Value Share Analysis, by Drug Class, 2021 and 2031
Figure 07: Global Prostaglandins Market Revenue (US$ Mn), 2021 to 2031
Figure 08: Global Beta Blockers Market Revenue (US$ Mn), 2021 to 2031
Figure 09: Global Alpha Agonist Market, Revenue (US$ Mn), 2021 to 2031
Figure 10: Global Carbonic Anhydrase Inhibitor (CAI) Market, Revenue (US$ Mn), 2021 to 2031
Figure 11: Global Combination Medications Market, Revenue (US$ Mn), 2021 to 2031
Figure 12: Global Cholinergic Market, Revenue (US$ Mn), 2021 to 2031
Figure 13: Global Market Attractiveness Analysis, by Drug Class
Figure 14: Global Market Value Share Analysis, by End-user, 2021 and 2031
Figure 15: Global Hospitals Market Revenue (US$ Mn), 2021 to 2031
Figure 16: Global Ophthalmic Clinics Market Revenue (US$ Mn), 2021 to 2031
Figure 17: Global Ambulatory Surgical Centers Market Revenue (US$ Mn), 2021 to 2031
Figure 18: Global Market Attractiveness Analysis, by End-user
Figure 19: Global Market Value Share Analysis, by Region, 2021 and 2031
Figure 20: Global Market Attractiveness Analysis, by Region, 2020 to 2031
Figure 21: North America Market Value (US$ Mn) Forecast, 2021 to 2031
Figure 22: North America Market Attractiveness Analysis, by Country
Figure 23: North America Market Value Share Analysis, by Drug Class, 2021 and 2031
Figure 24: North America Market Value Share Analysis, by End-user, 2021 and 2031
Figure 25: North America Market, by Country, 2021 and 2031
Figure 26: North America Market Attractiveness Analysis, by Drug Class
Figure 27: North America Market Attractiveness Analysis, by End-user
Figure 28: Europe Market Value (US$ Mn) Forecast, 2021 to 2031
Figure 29: Europe Market Attractiveness Analysis, by Country/Sub-Region
Figure 30: Europe Market Value Share Analysis, by Drug Class, 2021 and 2031
Figure 31: Europe Market Value Share Analysis, by End-user, 2021 and 2031
Figure 32: Europe Market, by Country/Sub-region
Figure 33: Europe Market Attractiveness Analysis, by Drug Class
Figure 34: Europe Market Attractiveness Analysis, by End-user
Figure 35: Asia Pacific Market Value (US$ Mn) Forecast, 2021 to 2031
Figure 36: Asia Pacific Market Attractiveness Analysis, by Country/Sub-Region
Figure 37: Asia Pacific Market Value Share Analysis, by Drug Class, 2021 and 2031
Figure 38: Asia Pacific Market Value Share Analysis, by End-user, 2021 and 2031
Figure 39: Asia Pacific Market, by Country/Sub-region
Figure 40: Asia Pacific Market Attractiveness Analysis, by Drug Class
Figure 41: Asia Pacific Market Attractiveness Analysis, by End-user
Figure 42: Latin America Market Value (US$ Mn) Forecast, 2021 to 2031
Figure 43: Latin America Market Attractiveness Analysis, by Country/Sub-region
Figure 44: Latin America Market Value Share Analysis, by Drug Class, 2021 and 2031
Figure 45: Latin America Market Value Share Analysis, by End-user, 2021 and 2031
Figure 46: North America Market, by Country/Sub-region
Figure 47: Latin America Market Attractiveness Analysis, by Drug Class
Figure 48: Latin America Market Attractiveness Analysis, by End-user
Figure 49: Middle East & Africa Market Value (US$ Mn) Forecast, 2021 to 2031
Figure 50: Middle East & Africa Market Attractiveness Analysis, by Country/Sub-region
Figure 51: Middle East & Africa Market Value Share Analysis, by Drug Class, 2021 and 2031
Figure 52: Middle East & Africa Market Value Share Analysis, by End-user, 2021 and 2031
Figure 53: Middle East & Africa Market, by Country/Sub-region
Figure 54: Middle East & Africa Market Attractiveness Analysis, by Drug Class
Figure 55: Middle East & Africa Market Attractiveness Analysis, by End-user
Figure 56: Global Market Share Analysis, by Company (2020)
